Robin E Ferner (Robin Ferner)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 23

Top Topics

Acute Heart Failure

Oral Anticoagulants

Top Venues

British journal of clinical pharmacology

Diabetic medicine : a journal of the British Diabetic Association

Pharmaceutical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Robin E Ferner, Jeffrey K Aronson
Competing Benefits and Competing Hazards: The Benefit to Harm Balance in Individual Patients in Rational Therapeutics. Drug safety 47 (8) (2024)
Robin E Ferner, Jeffrey K Aronson
Competing Benefits and Competing Hazards: The Benefit to Harm Balance in Individual Patients in Rational Therapeutics. Drug safety (2024)
Andrew Barron, Jennifer Chung, Robin E Ferner, Maria Leandro, Saloni Maru, Andrew Scourfield, Robert Urquhart, Reecha Sofat
Effectiveness of biosimilar adoption within a UK tertiary hospital; six-years follow up. British journal of clinical pharmacology (2023)
Sonali Sanghvi, Robin E Ferner, Andrew Scourfield, Robert Urquhart, Sejal Amin, Aroon D Hingorani, Reecha Sofat
How to assess pharmacogenomic tests for implementation in the NHS in England. British journal of clinical pharmacology (2023)
Harrison S France, Jeffrey K Aronson, Carl J Heneghan, Robin E Ferner, Anthony Richard Cox, Georgia C Richards
Preventable Deaths Involving Medicines: A Systematic Case Series of Coroners' Reports 2013-22. Drug safety (2023)
Emma J Moyns, Robin E Ferner
Treatment of insulin poisoning: A 100-year review. Diabetic medicine : a journal of the British Diabetic Association (2023)
Jeffrey K Aronson, Carl Heneghan, Robin E Ferner
Drug shortages. Part 1. Definitions and harms. British journal of clinical pharmacology (2023)
Robin E Ferner, Richard Brittain, Anthony Richard Cox, Carl J Heneghan, Georgia C Richards, Jeffrey K Aronson
Recognition of Coroners' Concerns to Prevent Future Deaths from Medicines: A Systematic Review. Pharmaceutical medicine (2023)
Robin E Ferner, Rachael Day, Sally M Bradberry
Phenytoin and damage to the cerebellum - a systematic review of published cases. Expert opinion on drug safety 21 (7) (2022)
Robin E Ferner, Jeffrey K Aronson
Medicines legislation and regulation in the United Kingdom 1500-2020. British journal of clinical pharmacology (2022)
Elizabeth Adeyeye, Carmela Maniero, Emma F Magavern, Robin E Ferner, Patricia McGettigan
Prescribing direct-acting oral anticoagulants - Mind the evidence gap. British journal of clinical pharmacology 88 (11) (2022)
Robin E Ferner, Richard John Stevens, Christopher G Anton, Jeffrey K Aronson
Spontaneous Reporting to Regulatory Authorities of Suspected Adverse Drug Reactions to COVID-19 Vaccines Over Time: The Effect of Publicity. Drug safety 45 (2) (2022)
Robin E Ferner, Julie Mason, Hannah K Vallance, Tanvi Choudhary, John F Marriott, Jamie J Coleman, Sarah K Pontefract
Coping with COVID: preparing prescribers during the pandemic. British journal of clinical pharmacology (2021)
Simon O'Callaghan, Robin E Ferner, Andrew Barron, Katherine Saxby, Reecha Sofat
Free-of-charge medicine schemes in the NHS: A local and regional drug and therapeutic committee's experience. British journal of clinical pharmacology (2021)
Frances Bennett, Robin E Ferner, Reecha Sofat
Overprescribing and rational therapeutics: Barriers to change and opportunities to improve. British journal of clinical pharmacology 87 (1) (2020)
Sonali Sanghvi, Rachel Allen, Steven Cho, Robin E Ferner, Robert Urquhart, Reecha Sofat
Are high-cost drug funding mechanisms fit for purpose? A retrospective study of individual funding requests in an NHS tertiary hospital. British journal of clinical pharmacology (2020)
Robin E Ferner, Jeffrey K Aronson
Medical Devices: Classification and Analysis of Faults Leading to Harms. Drug safety 43 (2) (2020)
Simon B Dimmitt, Christopher Nicholas Floyd, Robin E Ferner
Antithrombotic dose: Some observations from published clinical trials. British journal of clinical pharmacology 85 (10) (2019)
Katherine Saxby, Sonali Sanghvi, Pritesh N Bodalia, Robin E Ferner, Maria Leandro, Robert Urquhart, Reecha Sofat
A novel approach to support implementation of biosimilars within a UK tertiary hospital. British journal of clinical pharmacology 86 (1) (2019)
Robin E Ferner, Jeffrey K Aronson
Susceptibility to adverse drug reactions. British journal of clinical pharmacology 85 (10) (2019)
Nigel J Langford, Stephen R Morley, Robin E Ferner
The relationship between antemortem and postmortem morphine concentrations. Clinical toxicology (Philadelphia, Pa.) 57 (12) (2019)
Simon B Dimmitt, Hans G Stampfer, Jennifer H Martin, Robin E Ferner
Efficacy and toxicity of antihypertensive pharmacotherapy relative to effective dose 50. British journal of clinical pharmacology 85 (10) (2019)
Jeffrey K Aronson, Robin E Ferner
Unlicensed and off-label uses of medicines: definitions and clarification of terminology. British journal of clinical pharmacology 83 (12) (2017)